6,894 results match your criteria Transurethral Resection of the Prostate


Is Intravesical Prostatic Protrusion a Risk Factor for Hydronephrosis and Renal Insufficiency in Benign Prostate Hyperplasia Patients.

J Chin Med Assoc 2019 Mar 11. Epub 2019 Mar 11.

Department of Urology, Taipei Veterans General Hospital, Taiwan, ROC.

Background: Some patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) hesitate to undergo surgical treatment until acute urinary retention (AUR) occurs. Some of these patients have been found to have hydronephrosis or even renal insufficiency. This study aimed to analyze the risk factors for hydronephrosis in patients with AUR who needed to receive transurethral resection of the prostate (TURP). Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=02118582-900000000-9997
Publisher Site
http://dx.doi.org/10.1097/JCMA.0000000000000088DOI Listing
March 2019
1 Read

Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.

Acta Oncol 2019 Mar 18:1-10. Epub 2019 Mar 18.

a OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.

Purpose: To compare early and late toxicities, dosimetric parameters and quality of life (QoL) between conventionally fractionated proton beam therapy (PBT) and intensity-modulated radiation therapy (IMRT) in prostate cancer (PCA) patients.

Methods: Eighty-eight patients with localized PCA treated between 2013 and 2017 with either definitive PBT (31) or IMRT (57) were matched using propensity score matching on PCA risk group, transurethral resection of the prostate, prostate volume, diabetes mellitus and administration of anticoagulants resulting in 29 matched pairs. Early and late genitourinary (GU) and gastrointestinal (GI) toxicities according to Common Terminology Criteria for Adverse Events (CTCAE) and QoL based on EORTC-QLQ-C30/PR25 questionnaires were collected prospectively until 12 months after radiotherapy (RT). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2019.1581373DOI Listing

Effects of Isothermic Irrigation on Core Body Temperature During Endoscopic Urethral Stone Treatment Surgery Under Spinal Anesthesia: A Randomized Controlled Trial.

Urol J 2019 Mar 18. Epub 2019 Mar 18.

Department of Anesthesiology and Reanimation, Ahi Evran University Training and Research Hospital, Kırsehir, Turkey.

Purpose? Isothermic irrigation decreases the reduction in core temperature and shivering in patients undergoing transurethral resection of prostate gland but this effect has not been studied in patients undergoing endoscopic urethral stone treatment surgery. The current study is designed to study the effect of isothermic hydration on core temperature in patients scheduled for endoscopic urethral stone treatment surgery under spinal anesthesia. Materials and Methods? Sixty patients allocated randomly into two groups. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.22037/uj.v0i0.4524DOI Listing

The clinical application of combination suprapubic prostatectomy with transurethral resection of the prostate (TURP) in patients with large volume benign prostatic hyperplasia (BPH).

Urologia 2019 Mar 14:391560319834492. Epub 2019 Mar 14.

Department of Urology, Renmin Hospital, Wuhan University, Wuhan, China.

Objective:: To investigate the safety and efficacy of the combination of suprapubic prostatectomy with transurethral resection of the prostate (TURP) for the treatment of large volume benign prostatic hyperplasia (BPH).

Methods:: We retrospectively analyzed the clinical data of two methods of treatment with 60 cases of a large volume BPH (>100 g) from January 2011 to 2017; the methods were suprapubic prostatectomy and suprapubic prostatectomy combination with TURP, in which the single open group comprised 30 cases, treated using the former method, and the combined open group comprised the other 30 cases, treated using the latter method. In the combined open group, the residual prostate gland was removed by TURP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0391560319834492DOI Listing

[Clinical study of "point-line-surface-volume" four dimensional holmium laser enucleation of prostate for benign prostatic hyperplasia].

Zhonghua Wai Ke Za Zhi 2019 Mar;57(3):194-199

Department of Urology, Peking University Third Hospital, Beijing 100191, China.

To investigate application value of "point-line-surface-volume" four dimensional holmium laser enucleation of prostate (HoLEP) in the treatment of benign prostatic hyperplasia (BPH). From December 2016 to November 2017, the clinical data of 60 cases of BPH with the treatment of "Point-line-surface-volume" four dimensional HoLEP at Department of Urology, Peking University Third Hospital were analyzed retrospectively. The age was (73. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0529-5815.2019.03.007DOI Listing

[Delirium in geriatric urology patients].

Authors:
K F Becher

Urologe A 2019 Mar 11. Epub 2019 Mar 11.

Abteilung für Geriatrie und Frührehabilitation, Helios Hanseklinikum Stralsund GmbH, Große Parower Straße 47-53, 18435, Stralsund, Deutschland.

Background: Delirium is a common but often undiagnosed complication in geriatric patients following a major or minor operation. With 14-56% in patients over 70 years of age, it is one of the most frequent complications seen in hospitals. The link between the prescription of drugs with antimuscarinic effects and cognitive disturbance is also well known. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-019-0887-4DOI Listing
March 2019
1 Read

Intra-operative Oxycodone Reduced Postoperative Catheter-Related Bladder Discomfort Undergoing Transurethral Resection Prostate. A Prospective, Double Blind Randomized Study.

Urol J 2019 Jan 5. Epub 2019 Jan 5.

Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Ouhai District of Wenzhou, Zhejiang, P. R. China, 325000.

Purpose: To observe the efficacy of intravenously injected oxycodone intraoperative on postoperative urinary catheter-related bladder discomfort (CRBD).

Materials And Methods: Patients with ASA I-III received trans-urethral resection prostate under general anesthesia were observed. Patients were randomized allocated to the group control (n = 45) received placebo and the group oxycodone (n =46 ) received 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.22037/uj.v0i0.4267DOI Listing
January 2019
2 Reads

() expression as a predictor of oncological outcomes in patients with high-grade prostate cancer treated with primary androgen deprivation therapy: a cohort study.

BMJ Open 2019 Mar 8;9(3):e025161. Epub 2019 Mar 8.

Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Objectives: To determine whether () expression can be used as a biomarker to predict biochemical recurrence and prostate cancer-specific death in patients with high Gleason grade prostate cancer treated with androgen deprivation therapy (ADT) as monotherapy.

Methods: A multicentre retrospective cohort study identifying 149 patients treated with primary ADT for metastatic or non-metastatic prostate cancer with Gleason score 8-10 between 1999 and 2006. Patients planned for adjuvant radiotherapy at diagnosis were excluded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2018-025161DOI Listing
March 2019
1 Read

Outcome and complications of adjustable continence therapy (ProACT ) in the treatment of urinary incontinence after transurethral resection of the prostate: A multicenter study.

Neurourol Urodyn 2019 Mar 8. Epub 2019 Mar 8.

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Aim: To evaluate the outcome of adjustable continence balloons in the treatment of stress urinary incontinence (SUI) after transurethral resection of the prostate (TURP).

Methods: In two tertiary centers, adjustable continence balloons were implanted in 29 patients with post-TURP SUI between 2007 and 2018. Endpoints of this retrospective multicenter study were patient-reported changes in pad count and complications. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nau.23966DOI Listing

[Surgical treatment of benign prostatic hyperplasia-resection, vaporization or enucleation?]

Urologe A 2019 Mar;58(3):263-270

Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland.

Background: Benign prostatic hyperplasia (BPH) is the most common condition affecting the male lower urinary tract. Besides transurethral resection of the prostate (TURP), vaporization of the prostate and endoscopic enucleation of the prostate are available.

Objectives: To provide an overview of the current status of surgical therapies for BPH. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00120-019-0891-8
Publisher Site
http://dx.doi.org/10.1007/s00120-019-0891-8DOI Listing
March 2019
1 Read

Safety and effectiveness of bipolar transurethral resection of the prostate in patients under ongoing oral anticoagulation with coumarins or antiplatelet drug therapy compared to patients without anticoagulation/antiplatelet therapy.

J Endourol 2019 Mar 5. Epub 2019 Mar 5.

Luzerner Kantonsspital, 30748, Klinik für Urologie, Luzern, LU, Switzerland ;

Objective: To determine whether TURP is safe and effective in patients under ongoing therapeutic oral anticoagulation (OAC) or anti-platelet drug (APD) therapy.

Patients And Methods: We analyzed data on 276 consecutive TURP patients under ongoing APD therapy with acetylsalicylic acid (n=130) or clopidogrel (n=16) or ongoing OAC with phenprocoumon (n=57), without stopping or bridging the medication, compared to 73 TURP patients without APD/OAC.

Results: Outcomes of patients under acetylsalicylic acid were comparable to the controls. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2018.0879DOI Listing

Uncommon Penio-Scrotal Metastases of Prostate Cancer Detected on 68Ga PSMA PET/CT.

Clin Nucl Med 2019 Mar 1. Epub 2019 Mar 1.

From the Department of Nuclear Medicine and PET/CT, Mahajan Imaging Centre, and.

A 68-year-old man, a known case of carcinoma prostate (Gleason score 4 + 4), status post transurethral resection of prostate cancer and radiotherapy, on hormonal treatment with rising prostate-specific antigen 9.0 ng/mL and penile swelling underwent Ga-PSMA PET/CT scan for metastatic workup and restaging. The study revealed abnormal tracer uptake in the prostatic bed region, the pelvic and inguinal lymph nodes, and metastases to the glans of penis and scrotum. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002527DOI Listing
March 2019
1 Read

Artificial urinary sphincter longevity following transurethral resection of the prostate in the setting of prostate cancer.

World J Urol 2019 Mar 2. Epub 2019 Mar 2.

Division of Urology, NorthShore University HealthSystem, Evanston, USA.

Purpose: Refractory urinary incontinence after channel transurethral resection of the prostate (cTURP) (TURP in the setting of prostate cancer) is a rare occurrence treated with artificial urinary sphincter (AUS). We sought to characterize those patients receiving AUS after cTURP and understand device longevity.

Materials And Methods: We identified patients who underwent cTURP and AUS placement in SEER-Medicare from 2002 to 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02684-zDOI Listing
March 2019
1 Read

Systemic Comorbidity Burden Using the ACTIONS Phenotype Predicts Urologic Medication Discontinuation Following Transurethral Resection of the Prostate.

Urology 2019 Feb 26. Epub 2019 Feb 26.

Cleveland Clinic Foundation, Cleveland, OH.

Objective: To assess the impact of systemic comorbidities on a validated health phenotype score (ACTIONS: Anxiety, Cardiovascular, Testosterone, Insulin/diabetes, Obesity, Neurologic, Sleep apnea) on outcomes of transurethral resection of prostate (TURP) for benign prostatic hyperplasia (BPH) for symptoms and medication discontinuation.

Materials And Methods: Comorbidities of men undergoing TURP for BPH from 2004-15 were assessed with the validated ACTIONS phenotype totaling a score from 0-2 for each domain (Anxiety, Cardiovascular, Testosterone, Insulin/diabetes, Obesity, Neurologic, Sleep apnea). BPH medication discontinuation, change in International Prostate Symptom Score (IPSS), post-void residual (PVR), and patient satisfaction were assessed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.02.016DOI Listing
February 2019

Feasibility Of Transvesical Prostate Resection and Its Effect On Postoperative Complications.

Urology 2019 Feb 25. Epub 2019 Feb 25.

Denizli State of Hospital, Department of Urology, Denizli, Turkey. Electronic address:

Objective: To study the feasibility of transvesical prostate resection and its effect on urethral stricture.

Materials And Methods: We included 99 patients with symptomatic bladder outlet obstruction who underwent transvesical (TVRP; n:48) and transurethral (TURP; n:51) prostatectomy. We examined all the patients by means of digital rectal examination, transrectal ultrasound, and evaluated them by international prostate symptom score, quality of life score, uroflowmetric assessment and PSA level, and established definitive diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.01.037DOI Listing
February 2019

Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.

Prostate Cancer Prostatic Dis 2019 Feb 28. Epub 2019 Feb 28.

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Purpose: The purpose of this study is to compare the efficacy and safety of transurethral enucleation and resection of prostate for treatment of benign prostatic hyperplasia (BPH).

Materials And Methods: This meta-analysis was conducted through a systematic search before 1 September 2018. All included publications were randomized controlled trials (RCTs). Read More

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41391-019-0135-4
Publisher Site
http://dx.doi.org/10.1038/s41391-019-0135-4DOI Listing
February 2019
6 Reads

Selective Tetramodal Bladder Preservation Therapy Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.

BJU Int 2019 Feb 27. Epub 2019 Feb 27.

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Objectives: To evaluate the oncological and functional outcomes associated with selective tetramodal bladder-sparing therapy, comprising maximal transurethral resection of the bladder tumor (TURBT), induction chemoradiotherapy (CRT), and consolidative partial cystectomy (PC) with pelvic lymph node dissection (PLND).

Materials And Methods: This study analyzed 154 patients with non-metastatic muscle-invasive bladder cancer (MIBC) who were prospectively enrolled into the tetramodal bladder-preservation protocol. After TURBT and induction CRT, patients showing complete remission were offered consolidative PC with PLND for the achievement of bladder preservation. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.14736
Publisher Site
http://dx.doi.org/10.1111/bju.14736DOI Listing
February 2019
3 Reads

Stromal sarcoma of the prostate.

Can J Urol 2019 Feb;26(1):9683-9685

Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Primary spindle cell sarcoma of the prostate is exceedingly rare and accounts for 0.1% of all prostatic cancers. Typically, the disease course is rapid and portends a short and dismal prognosis. Read More

View Article

Download full-text PDF

Source
February 2019
7 Reads

Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction.

Ther Adv Urol 2019 Jan-Dec;11:1756287219828971. Epub 2019 Feb 14.

University of Thessaly, Faculty of Medicine, Department of Urology, Feidiou 6-8, 41221, Larissa, Greece.

Transurethral resection of the prostate (TURP) is considered the 'gold standard' for the surgical management of lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO). However, during recent years TURP has been challenged by several minimally invasive therapies (MITs). The reasons for the development of these MITs are the need for anesthesia and the rather unchanged morbidity of TURP, including ejaculation disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287219828971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376539PMC
February 2019

[Fake News BPH - what is really true!]

Urologe A 2019 Mar;58(3):271-283

Klinik für Urologie, Evangelisches Krankenhaus Oberhausen, Oberhausen, Deutschland.

Background: Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) is the fourth most common and the fifth most costly disease in men aged 50 years or older. Despite the high prevalence of LUTS/BPH in clinical practice and evidence-based guideline recommendations, there are still plenty of misconceptions on the terminology and pathophysiology of the disease, leading to false assumptions and malpractice.

Objectives: Listing of commonly used false assumptions and clarification of the correct terminology and pathophysiology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-019-0885-6DOI Listing

[Novel minimally invasive treatment options for male lower urinary tract symptom].

Urologe A 2019 Mar;58(3):254-262

Klinik für Urologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.

Novel minimally invasive treatment options strive for innovative approaches that are equally efficient to standard procedures with a superior safety profile. A true minimally invasive technique can be performed in an ambulatory setting under local anaesthesia and no need for postinterventional catheterization so that quick and problem-free return to everyday life is possible. Sexual dysfunction is a great concern of sexually active patients facing surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-019-0876-7DOI Listing

A prospective study to compare changes in male sexual function following holmium laser enucleation of prostate versus transurethral resection of prostate.

Urol Ann 2019 Jan-Mar;11(1):27-32

Department of Urology, Indraprastha Apollo Hospital, New Delhi, India.

Introduction: Transurethral resection of the prostate (TURP) and holmium laser enucleation of the prostate (HoLEP), both are considered standard endosurgical treatment of benign prostatic hyperplasia (BPH). Many studies have evaluated changes in sexual function following treatment of BPH. However, data are sparse on comparative study between the two standard options of the treatment of BPH. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/UA.UA_44_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362791PMC
February 2019

[Comparative observation of thulium laser resection of the prostate-tangerine technique and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia of various sizes].

Zhonghua Yi Xue Za Zhi 2019 Feb;99(6):423-427

Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550002, China.

To compare the efficiency and safety of thulium laser resection of the prostate-tangerine technique (TmLRP-TT) and transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH) of various sizes. Clinical data of 249 BPH patients received TmLRP-TT or TURP were retrospectively collected. Patients were divided into small prostate group [prostate volume (PV)<40 ml], medium prostate group (40 ml≤PV<80 ml) and large prostate group (PV ≥ 80 ml) based on transrectal ultrasound (TRUS) results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0376-2491.2019.06.008DOI Listing
February 2019
3 Reads

Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial).

Trials 2019 Feb 19;20(1):142. Epub 2019 Feb 19.

Division of Infectious Diseases and 721 Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben, 4031, Basel, Switzerland.

Background: Transurethral resection of the prostate (TURP) and Greenlight laser vaporisation (GL) of the prostate are frequently performed urological procedures. For TURP, a single-dose antimicrobial prophylaxis (AP) is recommended to reduce postoperative urinary tract infections. So far, no international recommendations for AP have been established for GL. Read More

View Article

Download full-text PDF

Source
https://trialsjournal.biomedcentral.com/articles/10.1186/s13
Publisher Site
http://dx.doi.org/10.1186/s13063-019-3237-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381623PMC
February 2019
4 Reads

Combined Low Dose Rate Brachytherapy and External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer.

J Med Imaging Radiat Sci 2019 Mar 8;50(1):82-86. Epub 2018 Nov 8.

The Austin Hospital, Heidelberg, Australia; Ringwood Private Hospital, Ringwood East, Australia; University of Melbourne, Melbourne, Australia.

Introduction: This is a retrospective study conducted to report the tumor control and late toxicity outcomes of patients with intermediate-risk prostate cancer undergoing combination external beam radiation therapy and low dose rate brachytherapy (LDR-PB).

Methods And Materials: Thirty-one patients received 45 Gray (Gy) of external beam radiation therapy to the prostate and seminal vesicles, together with a brachytherapy boost via a transperineal prostate implant of I (108 Gy). In addition, some patients received 6 months of androgen deprivation therapy depending on physician preference. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmir.2018.09.010DOI Listing
March 2019
4 Reads

Transurethral resection of the prostate with preservation of the bladder neck decreases postoperative retrograde ejaculation.

Wideochir Inne Tech Maloinwazyjne 2019 Jan 14;14(1):96-101. Epub 2018 Nov 14.

Department of Geriatric Medicine, Xiang Ya Hospital, Central South University, Changsha, China.

Introduction: Even though transurethral resection of the prostate (TURP) is the standard surgical treatment for benign prostatic hyperplasia (BPH), there is a high rate of postoperative retrograde ejaculation.

Aim: To evaluate the effectiveness of TURP with preservation of the bladder neck in comparison with that of standard TURP.

Material And Methods: This is a retrospective study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wiitm.2018.79536DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372866PMC
January 2019
1 Read

[Iatrogenic urethral structures in men].

Urologiia 2018 Oct(4):56-63

N.I. Pirogov RNRMU of Minzdrav of Russia, Department of Urology and Andrology, Moscow, Russia.

Introduction: Iatrogenic urethral damage is the leading etiologic factor for urethral stricture in men in developed countries and second after traumatic injury in developing ones. This study aimed to evaluate the frequency of iatrogenic strictures of the urethra and the results of their treatment.

Materials And Methods: This retrospective analysis comprised 133 patients who were treated for iatrogenic urethral stricture from 2011to 2016. Read More

View Article

Download full-text PDF

Source
October 2018

[First experience with prostate artery embolization for benign prostatic hyperplasia].

Urologiia 2018 Oct(4):33-37

Research Institute of Clinical and Experimental Lymphology a branch of Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the RAS, Novosibirsk, Russia.

This study aimed to evaluate the feasibility of the prostate artery embolization (PAE) in the management of patients with benign prostatic hyperplasia (BPH) in different age groups, depending on the severity of voiding dysfunction, findings of the prostate ultrasound, and the ASA surgical risk.

Materials And Methods: The study comprised 39 patients with grade II-III BPH. Patients were divided into three groups, depending on the prostate volume and the grade of anesthesia risk. Read More

View Article

Download full-text PDF

Source
October 2018

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Cochrane Database Syst Rev 2019 02 13;2:CD013143. Epub 2019 Feb 13.

Department of Urology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Korea, South.

Background: New, minimally invasive surgeries have emerged as alternatives to transurethral resection of the prostate (TURP) for the management of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). Aquablation is a novel, minimally invasive, water-based therapy, combining image guidance and robotics for the removal of prostatic tissue.

Objectives: To assess the effects of Aquablation for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD013143.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373984PMC
February 2019
1 Read

Porous Se@SiO nanosphere-coated catheter accelerates prostatic urethra wound healing by modulating macrophage polarization through reactive oxygen species-NF-κB pathway inhibition.

Acta Biomater 2019 Feb 10. Epub 2019 Feb 10.

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China. Electronic address:

Benign prostatic hyperplasia (BPH) patients experience complications after surgery. We studied oxidative stress scavenging by porous Se@SiO nanospheres in prostatic urethra wound healing after transurethral resection of the prostate (TURP). Beagle dogs were randomly distributed into two groups after establishing TURP models. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.actbio.2019.02.006DOI Listing
February 2019
1 Read

Antibiotic prophylaxis in TURP: a prospective analysis concerning antibiotic stewardship and a potential reduction of antibiotic use in TURP.

World J Urol 2019 Feb 9. Epub 2019 Feb 9.

Jessa Hospital, Stadsomvaart, 3050, Hasselt, Belgium.

Purpose: Antibiotic prophylaxis is standard procedure in transurethral resection of the prostate (TURP). We evaluated the necessity of antibiotic (AB) prophylaxis in TURP due to increasing microbial antibiotic resistance.

Methods: This is a prospective cohort study of 506 patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02676-zDOI Listing
February 2019

Proposal of a new way to evaluate the external sphincter function prior male sling surgey.

Int Braz J Urol 2019 Feb 10;45. Epub 2019 Feb 10.

Departamento de Cirurgia Urológica, Universidade Estadual de Campinas - UNICAMP, Campinas, SP, Brasil.

Objective: To propose a new way to objectively evaluate the external sphincter function prior to male sling surgery.

Materials And Methods: We evaluated the pre-operative sphincter function throughout sphincter pressure at rest (SPAR) and sphincter pressure under contraction (SPUC) obtained throughout urethral profilometry profile (UPP) of 10 consecutive patients (age range, 54-79 years) treated with the retrourethral transobturator sling (RTS) for stress urinary incontinence (SUI) because of prostate surgery. The primary endpoint for surgery success rate was post-operative pad weight test. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0146DOI Listing
February 2019

Urodynamic Outcomes After Aquablation.

Urology 2019 Feb 2. Epub 2019 Feb 2.

Tauranga, New Zealand; Department of Urology, Tauranga Hospital, Bay of Plenty District Health Board, Tauranga, New Zealand. Electronic address:

Objectives: To compare urodynamic outcomes between Aquablation vs transurethral resection of the prostate (TURP).

Methods: Patients were randomized 2:1 (Aquablation:TURP) in the Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue study. Urodynamics were measured at baseline and 6 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.01.020DOI Listing
February 2019
1 Read

Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.

J Vasc Interv Radiol 2019 Feb;30(2):228-232

Department of Radiology, University of Sao Paulo Medical School, Sao Paulo, Brazil.

Purpose: To compare the 12-month post-prostatic artery embolization (PAE) clinical outcomes of patients who were and were not taking 5-alpha-reductase inhibitors (5ARIs) at the time of PAE.

Materials And Methods: A retrospective review was conducted of patients who underwent PAE from 2010 to 2017 due to lower urinary tract symptoms, secondary to benign prostatic hyperplasia (BPH). One hundred fifty-five patients were included and divided in 2 groups; these groups did not present statistically significant differences in their baseline characteristics-those taking 5ARIs (Y-5ARIs, n = 40) and those not taking 5ARIs (N-5ARIs, n = 115). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2018.11.027DOI Listing
February 2019
1 Read

Association of receptor expression with prostate volume in benign prostatic hyperplasia.

Indian J Pathol Microbiol 2019 Jan-Mar;62(1):99-102

Department of Pathology, JIPMER, Puducherry, India.

Background: The expression of androgen (AR) and estrogen receptors (ER-A, ER-B) in Prostate cancer is well documented, but there are limited data about the same in patients with BPH. Hence the present study was designed to analyse the gene and protein expression of androgen and estrogen receptors in patients with BPH.

Materials And Methods: Prostatic tissues were obtained from 27 BPH patients aged between 55 to 85 years by transurethral resection of prostate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/IJPM.IJPM_315_18DOI Listing
February 2019

National trends in surgical therapy for benign prostatic hyperplasia in Australia.

ANZ J Surg 2019 Feb 1. Epub 2019 Feb 1.

Department of Urology, Westmead Hospital and Discipline of Surgery, The University of Sydney, Sydney, New South Wales, Australia.

Background: To determine national trends in the utilization of surgical procedures for the treatment of benign prostatic hyperplasia (BPH) in Australia over the last 20 years.

Methods: The Medicare Australia and Australian Institute of Health and Welfare databases were used to determine the annual number of surgical procedures and hospital admissions for BPH.

Results: From 1998 to 2017, surgical procedures for BPH have increased by 79% which is largely commensurate with population growth. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.15016DOI Listing
February 2019

Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.

World J Urol 2019 Jan 30. Epub 2019 Jan 30.

Department of Urology, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Purpose: Fatty acid-binding protein 5 (FABP5), a transport protein for lipophilic molecules, has been proposed as protein marker in prostate cancer (PCa). The role of FABP5 gene expression is merely unknown.

Methods: In two cohorts of PCa patients who underwent radical prostatectomy (n = 40 and n = 57) and one cohort of patients treated with palliative transurethral resection of the prostate (pTUR-P; n = 50) FABP5 mRNA expression was analyzed with qRT-PCR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02651-8DOI Listing
January 2019

Comparison of safety and efficacy of bipolar plasmakinetic transurethral enucleation and bipolar plasmakinetic transurethral resection of prostate gland greater than 60gm in patients receiving anticoagulants and/or platelet aggregation inhibitors: a tertiary care center experience.

Minerva Urol Nefrol 2019 Jan 28. Epub 2019 Jan 28.

Department of Urology and Renal Transplant, Dr. RMLIMS, Lucknow, India.

Background: To evaluate the safety and efficacy of Bipolar plasmakinetic enucleation of the prostate (BPEP) and Bipolar plasmakinetic transurethral resection of prostate (B-TURP) for patients on oral anticoagulants (OA) and/or platelet aggregation inhibitors (PAI) with benign prostatic obstruction (BPO) and having a gland size of >60 grams.

Methods: Patient database of our hospital for the period of May 2012 to September 2017 was retrospectively reviewed for BPH patients with a gland size of >60 g who either underwent BPEP or B-TURP and were on OA and/or PAI. Patient demographic, perioperative, and follow-up data were analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0393-2249.19.03282-XDOI Listing
January 2019
1 Read

Urethral stricture after bipolar transurethral resection of prostate - truth vs hype: A randomized controlled trial.

Indian J Urol 2019 Jan-Mar;35(1):41-47

Department of Urology, Hamdard Institute of Medical Sciences and Research, New Delhi, India.

Introduction: Bipolar transurethral resection of prostate (B-TURP) was introduced as an alternative procedure to minimize the surgical complications of monopolar TURP (M-TURP). However, there are concerns about increased incidence of stricture urethra (SU) post B-TURP. This study was designed to analyze the incidence of SU among patients undergoing M-TURP versus B-TURP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/iju.IJU_223_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334584PMC
January 2019
6 Reads

Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis.

BMC Urol 2019 Jan 28;19(1):11. Epub 2019 Jan 28.

Department of Urology, The Affiliated Hospital of Hang Zhou Normal University, Hangzhou, 310015, China.

Background: To compare the clinical efficiency and safety of transurethral resection of the prostate (TURP) and prostatic artery embolization (PAE) for the treatment of Benign prostatic hyperplasia (BPH).

Methods: We searched PUBMED, EMBASE and the Cochrane Central Register for studies from May 1998 to May 2018 for studies comparing the efficiency and safety of TURP with PAE. Four studies met the inclusion criteria for our meta-analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-019-0440-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350315PMC
January 2019
1 Read

Defining and discriminating responders from non-responders following transurethral resection of the prostate.

Scand J Urol 2018 Oct - Dec;52(5-6):437-444. Epub 2019 Jan 25.

b Institute of Clinical Sciences at the Sahlgrenska Academy , University of Gothenburg , Sweden.

Background: Transurethral resection of the prostate (TURP) is the reference standard surgical treatment for lower urinary tract symptoms (LUTS) related to benign prostatic enlargement. The aim of this study was to investigate the response rate following TURP in two distinctly different patient categories; men with bothersome LUTS and men in urinary retention (UR) requiring catheterisation.

Methods: In total, 355 men underwent TURP due to LUTS or UR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21681805.2018.1536677DOI Listing
January 2019

Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis.

Cent European J Urol 2018 5;71(4):410-419. Epub 2018 Nov 5.

LABIOMOL Research Group, Universidad del Valle, Cali, Colombia.

Introduction: To identify the association between the TMPRSS2:ERG fusion gene, their variants and the onset of localized prostate cancer.

Material And Methods: A systematic search strategy was carried out through MEDLINE, EMBASE, LILACS, CENTRAL and unpublished literature. We included randomized control trials, cohort, case-control and cross-sectional studies that involved patients >18 years-old assessing the association between TMPRSS2 fusion gene, its single nucleotide polymorphisms and prostate cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5173/ceju.2018.1752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338815PMC
November 2018
1 Read

Investigation of prostate resected weight on postoperative sexual dysfunction following transurethral resection of prostate surgery: a population-based study.

Ther Clin Risk Manag 2019 10;15:113-118. Epub 2019 Jan 10.

Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan,

Background: Benign prostate hyperplasia, a common disease in elderly men, can be surgically treated with transurethral resection of the prostate (TURP). Postoperative sexual dysfunction is a major issue and is influenced by many factors. The present study aimed to assess whether the intraoperative resected prostate weight influences the probability of postoperative sexual dysfunction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S186822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330969PMC
January 2019
2 Reads

Primary urothelial carcinoma of the prostate: A rare case report.

Medicine (Baltimore) 2019 Jan;98(3):e14155

Department of Urology, The First Affiliated Hospital of Anhui Medical University.

Rationale: Prostatic urothelial carcinoma is a rare disease. Medical misdiagnosis rates remain high because there are no specific clinical symptoms or imaging features, which decreases patient survival. We report a case of prostatic urethral cancer confirmed by transrectal ultrasound-guided prostate biopsy because of an abnormal digital rectal exam. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370032PMC
January 2019
2 Reads
5.723 Impact Factor

Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate: A population-based study.

Medicine (Baltimore) 2019 Jan;98(3):e13897

The Department of Anesthesiology, Chang Gung Memorial Hospital.

To analyze whether different volumes of tissue resected during transurethral resection of the prostate (TURP) would associate with the subsequent development of prostate cancer.This population-based retrospective cohort study recruited 49,206 patients with benign prostate hyperplasia (BPH) undergoing TURP between 2005 and 2012. Patients were recruited from the Taiwan National Health Insurance Research Database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370121PMC
January 2019

Expression of MUC1 in eosinophilic metaplasia of the prostate.

Prostate 2019 May 16;79(6):622-627. Epub 2019 Jan 16.

Department of Medical Biology, Medical University of Plovdiv, Plovdiv, Bulgaria.

Background: Eosinophilic metaplasia (EM) in the prostate is characterized by the presence of eosinophilic cytoplasmic granules in benign prostatic epithelium. These granules show exocrine-type morphology and positive expression for prostate specific antigen (PSA) and some lysosomal markers. The nature and the full immunohistochemical profile of the granules of EM have not been studied in detail yet. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23769DOI Listing

Tranexamic acid is beneficial for reducing perioperative blood loss in transurethral resection of the prostate.

Exp Ther Med 2019 Jan 28;17(1):943-947. Epub 2018 Nov 28.

Department of Anesthesiology, Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116027, P.R. China.

The aim of this randomized controlled trial was to evaluate the effect of tranexamic acid (TXA) on postoperative blood loss during transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). A total of 60 patients with BPH and undergoing TURP were randomized into TXA and control groups. Patients were intravenously administered 1 g TXA or placebo (0. Read More

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/10.3892/etm.2018.7025
Publisher Site
http://dx.doi.org/10.3892/etm.2018.7025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307403PMC
January 2019
5 Reads